Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000008:administration & dosage*; D000787:Angina Pectoris / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D005996:Nitroglycerin / Q000008:administration & dosage; D010919:Placebos; D013565:Sympatholytics / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D014717:Vertigo / Q000139:chemically induced
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D010919:Placebos; D013565:Sympatholytics; D005996:Nitroglycerin